📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Sector Averages

About

Wix.com Ltd. operates a cloud-based web development platform for registered users and creators in the United States, Europe, Israel, and internationally.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

⭐ Superinvestors Holding WIX

View All Superinvestors →

Manager	Shares	Value	% of Fund	Period
Cathie Wood ARK Investment Management	26.6K	$2.4M	0.02%	Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔍 Concall Decoded

🎙 Management Tone Tracker Confident Vague ↓ Deteriorating 3 quarters analysed

Q2 2025

Confident Specific

Management repeatedly used superlatives like 'extremely exciting', 'stronger than expected', 'haven't seen since peak COVID', and raised full-year guidance citing concrete cohort metrics (20%+ exit growth, 14% cohort booking growth). They provided specific ARR targets for Base44 ($40-50M by year-end).

Q3 2025

Confident Specific

Enthusiastic language about Base44 growth ('exploded', 'fantastic product', 'meaningfully outgrew peers'), honest acknowledgment of flagship product delay ('clearly unhappy'), and specific numeric milestones ($50M ARR, 14% revenue growth).

Q1 2026 latest

Confident Vague

Management expressed strong belief in Wix's competitive advantages (proprietary LLM, platform depth, AI integration) and highlighted positive trends (Base44 ARR growth, Harmony adoption) but remained vague on specifics like cohort breakdowns, Base44 retention curves, and the impact of the Middle East conflict on product timelines. Phrases like 'we believe', 'we are encouraged', and 'hard to quantify' signal confidence without full transparency.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis appears modestly stronger as Base44's rapid ARR growth and the proprietary LLM for Harmony provide tangible evidence of Wix's AI execution and cost control. However, the slower-than-expected Partners business, significant FX headwind, and war-related productivity drag temper the bullishness. The maintained guidance and the accretive share buyback signal management's confidence, but the lack of clear Partners recovery timeline and the reliance on Base44 for acceleration introduce uncertainty. Key items to watch next quarter: Partners business inflection, Base44 gross margin progression, and any further detail on the rollout of proprietary models for Base44 inference cost savings.

AI-generated concall tone analysis · Updated 2026-06-09 · Not investment advice

🎙 Management Tone Confident Vague ↓ Deteriorating 3 quarters Full tone analysis in Intelligence →

📊 MIXED Wix Q1 2026: Revenue $541M (+14%), Base44 ARR $150M, cohort bookings +46%.

Revenue & Profitability

Total bookings were $585 million (+15% YoY), and total revenue was $541 million (+14% YoY). Non-GAAP operating income was 5% of revenue. Free cash flow was $112 million (21% of revenue). Non-GAAP gross margin was 66%.

Outlook

Management expects mid-teens percentage growth in both bookings and revenue for full-year 2026. Partners growth is slower due to product delays and marketing pullback. A $64 million FX headwind on expenses is expected in H2 2026. Base44 growth continues on its current trajectory.

Growth Drivers

Growth is driven by strong new cohort behavior (46% bookings increase), Harmony's improved conversion and monetization, and Base44's rapid scaling (ARR reached $150M by mid-May). Partners grew 19% but slower than anticipated. GPV growth was soft at 12% due to macro pressure on SMBs.

Balance Sheet & CapEx

Significant investment in Base44 marketing and Super Bowl ads ($24M). Development of proprietary LLM for Harmony with low ongoing costs. No specific CapEx guidance was provided.

Margins

Non-GAAP gross margin was 66%, declining due to Base44 investments. Core Wix gross margins are stable. Base44 gross margins are expected to improve significantly through the year as optimization continues and front-loaded AI costs decline. Full-year free cash flow margin is expected to be high teens (excluding acquisition costs).

Key Risks

The war in the Middle East has impacted employee productivity, delaying Partner product timelines. FX headwind of $64 million in H2 2026. Slower-than-expected Partners growth. Macro pressure on SMBs is affecting GPV growth.

Generated by AI · Q1 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q2 2026 Q2 2026 2026-08-04

Revenue grew 15% and bookings 12% year-over-year in Q2, driven by strong Base44 and core business performance. Base44 gross margin improved to ~60% for H2, with all savings reinvested in sales and marketing. Guidance for 2026 is maintained, with continued focus on AI innovation and market share gains.

Q1 2026 Q1 2026 2026-05-13

Q1 2026 saw 15% bookings and 14% revenue growth, driven by strong new user cohorts and Base44's rapid ARR expansion. Proprietary AI investments, a major share repurchase, and robust free cash flow position the company for continued growth despite FX and competitive headwinds.

Q4 2025 Q4 2025 2026-03-04

Strong Q4 and full-year 2025 results with double-digit growth in bookings and revenue, driven by AI innovation and Base44 integration. 2026 guidance calls for mid-teens growth and continued investment, with a major share repurchase and new equity backing.

Q3 2025 Q3 2025 2025-11-19

Q3 saw 14% year-over-year growth in both revenue and bookings, with Base44 scaling rapidly and expected to reach $50 million ARR by year-end. Margin pressure from Base44's growth is expected to ease as the business matures, while strong core performance and strategic investments set up for continued expansion.

Q2 2025 Q2 2025 2025-08-06

Q2 2025 saw double-digit revenue and bookings growth, driven by strong new user cohorts, AI innovation, and rapid Base44 expansion. Full-year guidance was raised, with robust free cash flow and continued investment in growth and share repurchases.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.